Brief: Kopran Ltd Says USFDA Inspection At Kopran API Unit Mahad Concluded
28/04/2025 11:16
April 28 (Reuters) - Kopran Ltd KPRN.NS: USFDA INSPECTION AT KOPRAN API UNIT MAHAD CONCLUDED USFDA INSPECTION CONCLUDED WITHOUT ANY OBSERVATIONS INSPECTION WAS CONCLUDED WITHOUT ANY OBSERVATIONS Source text: ID:nBSE2MXWqG Further company coverage: KPRN.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Kopran
See all newsBrief: Kopran Says EU Medicine Authority Conducts GMP Inspection At Khopran Khopoli Facility Sept 18-23, 2026
Brief: Kopran June-Quarter Consol Profit 67 Million Rupees
India's Kopran rises as quarterly profit nearly doubles
Brief: Kopran March-Quarter Consol Net Profit 188.7 Million Rupees
Brief: Kopran Flags Cyber-Attack At Its Khopoli Factory